OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cognitive Impairment and Dementia in Parkinson Disease
Jennifer G. Goldman, Erica Sieg
Clinics in Geriatric Medicine (2020) Vol. 36, Iss. 2, pp. 365-377
Closed Access | Times Cited: 71
Jennifer G. Goldman, Erica Sieg
Clinics in Geriatric Medicine (2020) Vol. 36, Iss. 2, pp. 365-377
Closed Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
Copper Induces Cognitive Impairment in Mice via Modulation of Cuproptosis and CREB Signaling
Ying Zhang, Qian Zhou, Lu Lu, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 972-972
Open Access | Times Cited: 74
Ying Zhang, Qian Zhou, Lu Lu, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 972-972
Open Access | Times Cited: 74
Approach to Cognitive Impairment in Parkinson’s Disease
Qiang Zhang, Georgina M. Aldridge, Nandakumar S. Narayanan, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1495-1510
Open Access | Times Cited: 54
Qiang Zhang, Georgina M. Aldridge, Nandakumar S. Narayanan, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1495-1510
Open Access | Times Cited: 54
Frameworks for Parkinson’s Disease Rehabilitation Addressing When, What, and How
Miriam R. Rafferty, Ella Nettnin, Jennifer G. Goldman, et al.
Current Neurology and Neuroscience Reports (2021) Vol. 21, Iss. 3
Open Access | Times Cited: 42
Miriam R. Rafferty, Ella Nettnin, Jennifer G. Goldman, et al.
Current Neurology and Neuroscience Reports (2021) Vol. 21, Iss. 3
Open Access | Times Cited: 42
Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives
Elisa Mantovani, Chiara Zucchella, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 1, pp. 25-43
Closed Access | Times Cited: 19
Elisa Mantovani, Chiara Zucchella, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 1, pp. 25-43
Closed Access | Times Cited: 19
EEG entropy insights in the context of physiological aging and Alzheimer’s and Parkinson’s diseases: a comprehensive review
Alessia Cacciotti, Chiara Pappalettera, Francesca Miraglia, et al.
GeroScience (2024) Vol. 46, Iss. 6, pp. 5537-5557
Open Access | Times Cited: 7
Alessia Cacciotti, Chiara Pappalettera, Francesca Miraglia, et al.
GeroScience (2024) Vol. 46, Iss. 6, pp. 5537-5557
Open Access | Times Cited: 7
Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
Yıldız Değirmenci, Efthalia Angelopoulou, Vasiliki Georgakopoulou, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1756-1756
Open Access | Times Cited: 14
Yıldız Değirmenci, Efthalia Angelopoulou, Vasiliki Georgakopoulou, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1756-1756
Open Access | Times Cited: 14
Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
Lisi Xu, Ruonan Zhang, Xiaolin Zhang, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Lisi Xu, Ruonan Zhang, Xiaolin Zhang, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Non-pharmacological Rehabilitation for People Living with Advanced Parkinson’s Disease: A Scoping Review of Interventions
Johanne Andersen Elbek, Birgitte Nørgaard, Tina H. Pedersen, et al.
Parkinsonism & Related Disorders (2025), pp. 107317-107317
Closed Access
Johanne Andersen Elbek, Birgitte Nørgaard, Tina H. Pedersen, et al.
Parkinsonism & Related Disorders (2025), pp. 107317-107317
Closed Access
The Inflammatory Mechanism of Parkinson’s Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut–Brain Axis
Ai Gao, Jiaqi Lv, Yanwei Su
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 159-159
Open Access
Ai Gao, Jiaqi Lv, Yanwei Su
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 159-159
Open Access
Awareness of national dementia guidelines and management of oldest-old and frail people living with dementia: a European survey of geriatricians
Elke De Bondt, Phaedra Locquet, María F. Lopez, et al.
European Geriatric Medicine (2025)
Closed Access
Elke De Bondt, Phaedra Locquet, María F. Lopez, et al.
European Geriatric Medicine (2025)
Closed Access
Concealment of Parkinsons disease prevalence and impact on health and quality of life
Badera Naamneh-Abuelhija, Michal Kafri, Meir Kestenbaum, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Badera Naamneh-Abuelhija, Michal Kafri, Meir Kestenbaum, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Epigenetic regulation of iron metabolism and ferroptosis in Parkinson’s disease: Identifying novel epigenetic targets
Xiaodie Gao, Jun Ding, Junxia Xie, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Xiaodie Gao, Jun Ding, Junxia Xie, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Overdosing on iron: Elevated iron and degenerative brain disorders
Santosh R. D’Mello, Mark C Kindy
Experimental Biology and Medicine (2020) Vol. 245, Iss. 16, pp. 1444-1473
Open Access | Times Cited: 36
Santosh R. D’Mello, Mark C Kindy
Experimental Biology and Medicine (2020) Vol. 245, Iss. 16, pp. 1444-1473
Open Access | Times Cited: 36
Cognition and serotonin in Parkinson's disease
Imane Frouni, Cynthia Kwan, Sébastien Belliveau, et al.
Progress in brain research (2022), pp. 373-403
Closed Access | Times Cited: 21
Imane Frouni, Cynthia Kwan, Sébastien Belliveau, et al.
Progress in brain research (2022), pp. 373-403
Closed Access | Times Cited: 21
Pathological Correlates of Cognitive Decline in Parkinson’s Disease: From Molecules to Neural Networks
Н Ю Новиков, E. S. Brazhnik, Valentina Kitchigina
Biochemistry (Moscow) (2023) Vol. 88, Iss. 11, pp. 1890-1904
Closed Access | Times Cited: 11
Н Ю Новиков, E. S. Brazhnik, Valentina Kitchigina
Biochemistry (Moscow) (2023) Vol. 88, Iss. 11, pp. 1890-1904
Closed Access | Times Cited: 11
Dopamine in the prefrontal cortex plays multiple roles in the executive function of patients with Parkinson's disease
Zihang Zhou, Yalong Yan, Heng Gu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 8, pp. 1759-1767
Open Access | Times Cited: 11
Zihang Zhou, Yalong Yan, Heng Gu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 8, pp. 1759-1767
Open Access | Times Cited: 11
Lipid metabolic dysregulation is involved in Parkinson’s disease dementia
Mei-Xue Dong, Youdong Wei, Ling Hu
Metabolic Brain Disease (2021) Vol. 36, Iss. 3, pp. 463-470
Closed Access | Times Cited: 24
Mei-Xue Dong, Youdong Wei, Ling Hu
Metabolic Brain Disease (2021) Vol. 36, Iss. 3, pp. 463-470
Closed Access | Times Cited: 24
Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson’s disease
Kyum‐Yil Kwon, Suyeon Park, Rae On Kim, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Kyum‐Yil Kwon, Suyeon Park, Rae On Kim, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
Yulia Aleksandrova, Kirill Chaprov, Alexandra V. Podturkina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5842-5842
Open Access | Times Cited: 10
Yulia Aleksandrova, Kirill Chaprov, Alexandra V. Podturkina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5842-5842
Open Access | Times Cited: 10
Parkinson’s Disease Dementia Patients: Expression of Glia Maturation Factor in the Brain
Ramasamy Thangavel, Harleen Kaur, Iuliia Dubova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1182-1182
Open Access | Times Cited: 3
Ramasamy Thangavel, Harleen Kaur, Iuliia Dubova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1182-1182
Open Access | Times Cited: 3
Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron
Jiajun Han, Yaohua Fan, Peipei Wu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 21
Jiajun Han, Yaohua Fan, Peipei Wu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 21
Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson's disease
Dian-Shuai Gao, Chuanxi Tang, Jing Chen, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 5, pp. 1107-1107
Open Access | Times Cited: 15
Dian-Shuai Gao, Chuanxi Tang, Jing Chen, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 5, pp. 1107-1107
Open Access | Times Cited: 15
Neuromodulation of cognition in Parkinson's disease
Rachel C. Cole, Derrick Okine, Brooke E. Yeager, et al.
Progress in brain research (2022), pp. 435-455
Open Access | Times Cited: 12
Rachel C. Cole, Derrick Okine, Brooke E. Yeager, et al.
Progress in brain research (2022), pp. 435-455
Open Access | Times Cited: 12
Advanced technologies applied to physical exercise for dementia and Alzheimer’s disease management: a narrative review
Martina Sortino, Alessandra Amato, Giuseppe Musumeci
Advanced technology in neuroscience . (2024) Vol. 1, Iss. 1, pp. 72-85
Closed Access | Times Cited: 2
Martina Sortino, Alessandra Amato, Giuseppe Musumeci
Advanced technology in neuroscience . (2024) Vol. 1, Iss. 1, pp. 72-85
Closed Access | Times Cited: 2
